Anna L. Eichenberger - University Hospital of Bern

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 7 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Antibody Response in Immunocompromised Patients after the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine BNT162b2 or Mrna-1273: A Randomized Controlled Trial

Clinical infectious diseases/Clinical infectious diseases (Online University of Chicago Press)no. 1 (2022): e585-e593

Cited22Views0WOSBibtex

A Trial Platform to Assess Approved SARS-CoV-2 Vaccines in Immunocompromised Patients: First Sub-Protocol for a Pilot Trial Comparing the Mrna Vaccines Comirnaty® and Covid-19 Mrna Vaccine Moderna®

University of Oxford,Chammartin Frédérique,Smith Daniel,Stoeckle Marcel P.,Amico Patrizia,Eichenberger Anna L.,Hasse Barbara,Schuurmans Macé M.,Müller Thomas,Tamm Michael,Dickenmann Michael, University Hospital Zurich,Trkola Alexandra,Hirsch Hans H.,Manuel Oriol,Cavassini Matthias, Stanford University, McMaster University,Mueller Nicolas J.,Rauch Andri,Koller Michael T.,Bucher Heiner C.

Trials（2021）

Cited6Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn